Title: Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients
Authors: Annemans, L ×
Moeremans, K
Lamotte, M
Garcia Conde, J
van den Berg, H
Myint, H
Pieters, R
Uyttebroeck, Anne #
Issue Date: Apr-2003
Publisher: Springer International
Series Title: Supportive Care in Cancer vol:11 issue:4 pages:249-57
Abstract: Hyperuricaemia (HU) and tumour lysis syndrome (TLS) are complications of acute myeloid/lymphoid leukaemia (AML/ALL) and non-Hodgkin lymphoma (NHL) leading to increased morbidity and mortality. The objective was to assess incremental cost-effectiveness ratios (ICER) of preventing/treating HU and TLS with recombinant urate oxidase, rasburicase (Fasturtec/Elitek).
ISSN: 0941-4355
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science